<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35934227</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Rottlerin plays an antiviral role at early and late steps of Zika virus infection.</ArticleTitle><Pagination><StartPage>685</StartPage><EndPage>694</EndPage><MedlinePgn>685-694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2022.07.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(22)00136-5</ELocationID><Abstract><AbstractText>Infection of Zika virus (ZIKV) may cause microcephaly and other neurological disorders, while no vaccines and drugs are available. Our study revealed that rottlerin confers a broad antiviral activity against several enveloped viruses, including ZIKV, vesicular stomatitis virus, and herpes simplex virus, but not against two naked viruses (enterovirus 71 and encephalomyocarditis virus). Rottlerin does not have a direct virucidal effect on the virions, and its antiviral effect is independent of its regulation on PKC&#x3b4; or ATP. Both pretreatment and post-treatment of rottlerin effectively reduce the viral replication of ZIKV. The pretreatment of rottlerin disturbs the endocytosis of enveloped viruses, while the post-treatment of rottlerin acts at a late stage through disturbing the maturation of ZIKV. Importantly, administration of rottlerin in neonatal mice significantly decreased the ZIKV replication in vivo, and alleviated the neurological symptoms caused by ZIKV. Our work suggests that rottlerin exerts an antiviral activity at two distinct steps of viral infection, and can be potentially developed as a prophylactic and therapeutic agent.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Publishing services by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shili</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, 510080, China; Medical Research Center, Guangdong Second Provincial General Hospital, Guangzhou, 510317, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Quanshi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, 510080, China; Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Changbai</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, 510080, China; Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Xiaotong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, 510080, China; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, 510080, China; Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, 510080, China; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China. Electronic address: liuchao9@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, 510080, China; Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China. Electronic address: zhangp36@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000098">Acetophenones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001578">Benzopyrans</NameOfSubstance></Chemical><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>E29LP3ZMUH</RegistryNumber><NameOfSubstance UI="C085746">rottlerin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000098" MajorTopicYN="N">Acetophenones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001578" MajorTopicYN="N">Benzopyrans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="Y">Zika Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="Y">Zika Virus Infection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enveloped virus</Keyword><Keyword MajorTopicYN="N">Replication</Keyword><Keyword MajorTopicYN="N">Rottlerin</Keyword><Keyword MajorTopicYN="N">Zika virus (ZIKV)</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>7</Day><Hour>19</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35934227</ArticleId><ArticleId IdType="pmc">PMC9583117</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2022.07.012</ArticleId><ArticleId IdType="pii">S1995-820X(22)00136-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdelnabi R., Amrun S.N., Ng L.F., Leyssen P., Neyts J., Delang L. Protein kinases C as potential host targets for the inhibition of chikungunya virus replication. Antivir. Res. 2017;139:79&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">28039020</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Shi Q., Pei F., Vogt A., Porritt R.A., Garcia G., Jr., Gomez A.C., Cheng M.H., Schurdak M.E., Liu B., Chan S.Y., Arumugaswami V., Stern A.M., Taylor D.L., Arditi M., Bahar I. A&#xa0;systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection. Mol. Syst. Biol. 2021;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8328275</ArticleId><ArticleId IdType="pubmed">34339582</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras X., Mzoughi O., Gaston F., Peterlin M.B., Bahraoui E. Protein kinase C-delta regulates HIV-1 replication at an early post-entry step in macrophages. Retrovirology. 2012;9:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3432598</ArticleId><ArticleId IdType="pubmed">22554282</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese M., Goellner S., Acosta E.G., Neufeldt C.J., Oleksiuk O., Lampe M., Haselmann U., Funaya C., Schieber N., Ronchi P., Schorb M., Pruunsild P., Schwab Y., Chatel-Chaix L., Ruggieri A., Bartenschlager R. Ultrastructural characterization of Zika virus replication factories. Cell Rep. 2017;18:2113&#x2013;2123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5340982</ArticleId><ArticleId IdType="pubmed">28249158</ArticleId></ArticleIdList></Reference><Reference><Citation>Daikonya A., Katsuki S., Wu J.B., Kitanaka S. Anti-allergic agents from natural sources (4): anti-allergic activity of new phloroglucinol derivatives from Mallotus philippensis (Euphorbiaceae) Chem. Pharm. Bull. (Tokyo) 2002;50:1566&#x2013;1569.</Citation><ArticleIdList><ArticleId IdType="pubmed">12499591</ArticleId></ArticleIdList></Reference><Reference><Citation>Filone C.M., Hanna S.L., Caino M.C., Bambina S., Doms R.W., Cherry S. Rift valley fever virus infection of human cells and insect hosts is promoted by protein kinase C epsilon. PLoS One. 2010;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2991366</ArticleId><ArticleId IdType="pubmed">21124804</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant A., Ponia S.S., Tripathi S., Balasubramaniam V., Miorin L., Sourisseau M., Schwarz M.C., Sanchez-Seco M.P., Evans M.J., Best S.M., Garcia-Sastre A. Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe. 2016;19:882&#x2013;890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4900918</ArticleId><ArticleId IdType="pubmed">27212660</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamel R., Dejarnac O., Wichit S., Ekchariyawat P., Neyret A., Luplertlop N., Perera-Lecoin M., Surasombatpattana P., Talignani L., Thomas F., Cao-Lormeau V.M., Choumet V., Briant L., Despres P., Amara A., Yssel H., Misse D. Biology of Zika virus infection in human skin cells. J.&#xa0;Virol. 2015;89:8880&#x2013;8896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524089</ArticleId><ArticleId IdType="pubmed">26085147</ArticleId></ArticleIdList></Reference><Reference><Citation>Ietta F., Maioli E., Daveri E., Gonzaga Oliveira J., da Silva R.J., Romagnoli R., Cresti L., Maria Avanzati A., Paulesu L., Barbosa B.F., Gomes A.O., Roberto Mineo J., Ferro E.A.V. Rottlerin-mediated inhibition of Toxoplasma gondii growth in BeWo trophoblast-like cells. Sci. Rep. 2017;7:1279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5430667</ArticleId><ArticleId IdType="pubmed">28455500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii R., Horie M., Saito K., Arisawa M., Kitanaka S. Prostaglandin E(2) production and induction of prostaglandin endoperoxide synthase-2 is inhibited in a murine macrophage-like cell line, RAW 264.7, by Mallotus japonicus phloroglucinol derivatives. Biochim. Biophys. Acta. 2002;1571:115&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">12049791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y.L., Oh C., Ahn S.H., Choi J.C., Choi H.Y., Lee S.W., Choi I.S., Song C.S., Lee J.B., Park S.Y. Inhibition of endocytosis of porcine reproductive and respiratory syndrome virus by rottlerin and its potential prophylactic administration in piglets. Antivir. Res. 2021;195</Citation><ArticleIdList><ArticleId IdType="pubmed">34678331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuno G., Chang G.J. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch. Virol. 2007;152:687&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">17195954</ArticleId></ArticleIdList></Reference><Reference><Citation>Lama Z., Gaudin Y., Blondel D., Lagaudriere-Gesbert C. Kinase inhibitors tyrphostin 9 and rottlerin block early steps of rabies virus cycle. Antivir. Res. 2019;168:51&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">31071352</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear H.M., Diamond M.S. Zika virus: new clinical syndromes and its emergence in the western hemisphere. J.&#xa0;Virol. 2016;90:4864&#x2013;4875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4859708</ArticleId><ArticleId IdType="pubmed">26962217</ArticleId></ArticleIdList></Reference><Reference><Citation>Maioli E., Greci L., Soucek K., Hyzdalova M., Pecorelli A., Fortino V., Valacchi G. Rottlerin inhibits ROS formation and prevents NFkappaB activation in MCF-7 and HT-29 cells. J.&#xa0;Biomed. Biotechnol. 2009;2009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820285</ArticleId><ArticleId IdType="pubmed">20168983</ArticleId></ArticleIdList></Reference><Reference><Citation>Maioli E., Torricelli C., Valacchi G. Rottlerin and cancer: novel evidence and mechanisms. Sci. World J. 2012;2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3259573</ArticleId><ArticleId IdType="pubmed">22272173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori N., Ishikawa C., Senba M. Activation of PKC-delta in HTLV-1-infected T cells. Int. J. Oncol. 2015;46:1609&#x2013;1618.</Citation><ArticleIdList><ArticleId IdType="pubmed">25625567</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhopadhyay S., Kuhn R.J., Rossmann M.G. A&#xa0;structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 2005;3:13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">15608696</ArticleId></ArticleIdList></Reference><Reference><Citation>Musso D., Gubler D.J. Zika virus. Clin. Microbiol. Rev. 2016;29:487&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4861986</ArticleId><ArticleId IdType="pubmed">27029595</ArticleId></ArticleIdList></Reference><Reference><Citation>Oehler E., Watrin L., Larre P., Leparc-Goffart I., Lastere S., Valour F., Baudouin L., Mallet H., Musso D., Ghawche F. Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013. Euro Surveill. 2014;19</Citation><ArticleIdList><ArticleId IdType="pubmed">24626205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojha D., Winkler C.W., Leung J.M., Woods T.A., Chen C.Z., Nair V., Taylor K., Yeh C.D., Tawa G.J., Larson C.L., Zheng W., Haigh C.L., Peterson K.E. Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons. Nat Microbiol. 2021;6:1398&#x2013;1409.</Citation><ArticleIdList><ArticleId IdType="pubmed">34675384</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojha D., Woods T.A., Peterson K.E. Drug-screening strategies for inhibition of virus-induced neuronal cell death. Viruses. 2021;13:2317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619239</ArticleId><ArticleId IdType="pubmed">34835123</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliphant T., Engle M., Nybakken G.E., Doane C., Johnson S., Huang L., Gorlatov S., Mehlhop E., Marri A., Chung K.M., Ebel G.D., Kramer L.D., Fremont D.H., Diamond M.S. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 2005;11:522&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1458527</ArticleId><ArticleId IdType="pubmed">15852016</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey S., Chatterjee A., Jaiswal S., Kumar S., Ramachandran R., Srivastava K.K. Protein kinase C-delta inhibitor, Rottlerin inhibits growth and survival of mycobacteria exclusively through Shikimate kinase. Biochem. Biophys. Res. Commun. 2016;478:721&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">27498028</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson T.C., Diamond M.S. The emergence of Zika virus and its new clinical syndromes. Nature. 2018;560:573&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">30158602</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson T.C., Graham B.S. Zika virus: immunity and vaccine development. Cell. 2016;167:625&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5074878</ArticleId><ArticleId IdType="pubmed">27693357</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghu H., Sharma-Walia N., Veettil M.V., Sadagopan S., Chandran B. Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells. J.&#xa0;Virol. 2009;83:4895&#x2013;4911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682094</ArticleId><ArticleId IdType="pubmed">19279100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandgren K.J., Wilkinson J., Miranda-Saksena M., McInerney G.M., Byth-Wilson K., Robinson P.J., Cunningham A.L. A&#xa0;differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells. PLoS Pathog. 2010;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2858709</ArticleId><ArticleId IdType="pubmed">20421949</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuler-Faccini L., Ribeiro E.M., Feitosa I.M., Horovitz D.D., Cavalcanti D.P., Pessoa A., Doriqui M.J., Neri J.I., Neto J.M., Wanderley H.Y., Cernach M., El-Husny A.S., Pone M.V., Serao C.L., Sanseverino M.T. Brazilian medical genetics society-zika embryopathy task, F., 2016. Possible association between Zika virus infection and microcephaly - Brazil. MMWR Morb. Mortal. Wkly. Rep. 2015;65:59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">26820244</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivshankar P., Lei L., Wang J., Zhong G. Rottlerin inhibits chlamydial intracellular growth and blocks chlamydial acquisition of sphingolipids from host cells. Appl. Environ. Microbiol. 2008;74:1243&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2258579</ArticleId><ArticleId IdType="pubmed">18083882</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiasny K., Fritz R., Pangerl K., Heinz F.X. Molecular mechanisms of flavivirus membrane fusion. Amino Acids. 2011;41:1159&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pubmed">19882217</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia J.A., Jensen R.T., Garcia-Marin L.J. Rottlerin inhibits stimulated enzymatic secretion and several intracellular signaling transduction pathways in pancreatic acinar cells by a non-PKC-delta-dependent mechanism. Biochim. Biophys. Acta. 2006;1763:25&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">16364465</ArticleId></ArticleIdList></Reference><Reference><Citation>Torricelli C., Fortino V., Capurro E., Valacchi G., Pacini A., Muscettola M., Soucek K., Maioli E. Rottlerin inhibits the nuclear factor kappaB/cyclin-D1 cascade in MCF-7 breast cancer cells. Life Sci. 2008;82:638&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">18261747</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsetsarkin K.A., Kenney H., Chen R., Liu G., Manukyan H., Whitehead S.S., Laassri M., Chumakov K., Pletnev A.G. A&#xa0;full-length infectious cDNA clone of Zika virus from the 2015 epidemic in Brazil as a genetic platform for studies of virus-host interactions and vaccine development. mBio. 2016;7:e01114&#x2013;e01116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4999549</ArticleId><ArticleId IdType="pubmed">27555311</ArticleId></ArticleIdList></Reference><Reference><Citation>Valacchi G., Pecorelli A., Sticozzi C., Torricelli C., Muscettola M., Aldinucci C., Maioli E. Rottlerin exhibits antiangiogenic effects in vitro. Chem. Biol. Drug Des. 2011;77:460&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">21435184</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Thurmond S., Hai R., Song J. Structure and function of Zika virus NS5 protein: perspectives for drug design. Cell. Mol. Life Sci. 2018;75:1723&#x2013;1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911220</ArticleId><ArticleId IdType="pubmed">29423529</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Deng Y.Q., Zou P., Wang Q., Dai Y., Yu F., Du L., Zhang N.N., Tian M., Hao J.N., Meng Y., Li Y., Zhou X., Fuk-Woo Chan J., Yuen K.Y., Qin C.F., Jiang S., Lu L. A&#xa0;peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat. Commun. 2017;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5537589</ArticleId><ArticleId IdType="pubmed">28742068</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng F., Li N., Xu Y., Zhou Y., Li Y.P. Adaptive mutations promote hepatitis C virus assembly by accelerating core translocation to the endoplasmic reticulum. J.&#xa0;Biol. Chem. 2021;296</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7949066</ArticleId><ArticleId IdType="pubmed">33144326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Yang C., Zhao F., Huang Y., Lin Y., Huang C., Ma X., Du J., Wang Y., Long G., He J., Liu C., Zhang P. Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR. J.&#xa0;Biol. Chem. 2019;294:18168&#x2013;18180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6885634</ArticleId><ArticleId IdType="pubmed">31636123</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>